OpenLegislation

Regulation 18 Marking of bottles and other containersI1

Northern Ireland

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

(1)

Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—

(a)

in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;

(b)

in the case of a controlled drug which is a preparation—

(i)

made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;

(ii)

not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.

(2)

Nothing in this regulation shall have effect in relation to—

(a)

the drugs specified in Schedules 4 and 5 or poppy-straw;

(b)

any drug specified in Schedule 3 contained in or comprising a preparation which—

(i)

is required for use as a buffering agent in chemical analysis;

(ii)

has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and

(iii)

is premixed in a kit;

(c)

any exempt product;

(d)

the supply of a controlled drug by or on the prescription of a practitioner;

(e)

the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.

(3)

In this regulation, the expressions “clinical trial” and “medicinal test on animals” have the same meanings as in the Medicines Act 1968.

Annotations

Commencement

I1

Reg. 18 in operation at 1.2.2002, see reg. 1